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Abstract
Background: Lymphatic filariasis (LF) is a debilitating disease associated with extensive disfigurement and is one of
a diverse group of diseases referred to as neglected tropical diseases (NTDs) which mainly occur among the poorest
populations. In line with global recommendations to eliminate LF, Kenya launched its LF elimination programme in
2002 with the aim to implement annual mass drug administration (MDA) in order to interrupt LF transmission.
However, the programme faced financial and administrative challenges over the years such that sustained annual
MDA was not possible. Recently, there has been renewed interest to eliminate LF and the Kenyan Ministry of
Health, through support from World Health Organization (WHO), restarted annual MDA in 2015. The objective of
this study was to evaluate the current status of LF infection in the endemic coastal region of Kenya before MDA
campaigns were restarted.
Results: Ten sentinel sites in Kwale, Kilifi, Tana River, Lamu, and Taita-Taveta counties in coastal Kenya were selected for
participation in a cross-sectional survey of LF infection prevalence. At least 300 individuals in each sentinel village were
sampled through random house-to-house visits. During the day, the point-of-care immunochromatographic test (ICT) was
used to detect the presence of Wuchereria bancrofti circulating filarial antigen in finger prick blood samples collected from
residents of the selected sentinel villages. Those individuals who tested positive with the ICT test were requested
to provide a night-time blood sample for microfilariae (MF) examination. The overall prevalence of filarial antigenaemia
was 1.3% (95% CI: 0.9–1.8%). Ndau Island in Lamu County had the highest prevalence (6.3%; 95% CI: 4.1–9.7%), whereas
sites in Kilifi and Kwale counties had prevalences < 1.7%. Mean microfilarial density was also higher in Ndau Island
(234 MF/ml) compared to sentinel sites in Kwale and Kilifi counties (< 25 MF/ml). No LF infection was detected in
Tana River and Taita-Taveta counties. Overall, more than 88% of the study participants reported to have used a
bed net the previous night.
Conclusions: Prevalence of LF infection is generally very low in coastal Kenya, but there remain areas that
require further rounds of MDA if the disease is to be eliminated as a public health problem in line with the ongoing
global elimination efforts. However, areas where there was no evidence of LF transmission should be considered for
WHO-recommended transmission assessment surveys in view of stopping MDA.
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Background
In 2000, the World Health Organization (WHO) launched
the Global Programme to Eliminate Lymphatic Filariasis
(GPELF) in response to World Health Assembly resolution
WHA50.29, which urged Member States to initiate
activities to eliminate lymphatic filariasis (LF), a goal
subsequently targeted for 2020 [1]. The GPELF has
two principal aims: (i) to interrupt LF transmission,
and (ii) to manage morbidity and prevent disability.
To interrupt transmission of LF infection, the GPELF
recommends annual community-wide mass drug adminis-
tration (MDA) of antifilarial tablets to entire at-risk popula-
tions aged two years and above for 4–6 years at adequate
levels of coverage. Modeling studies have estimated
adequate treatment coverage to be at least 65% of total
population in endemic areas [2, 3].
In Kenya, LF is confined to the coastal region where
ecological factors are suitable for its transmission [4].
The Kenyan Ministry of Health (MoH) launched its LF
elimination programme in 2002 when MDA was launched
in the then Kilifi District. Unlike in many other African
countries, onchocerciasis is not endemic in the LF endemic
coastal Kenya. Therefore, the recommended antifilarial
treatment for MDA is single-dose annual mass treatment
with diethylcarbamazine citrate (DEC, 6 mg/kg) plus alben-
dazole (400 mg). In 2003, the programme was scaled up to
include Kwale and Malindi Districts. Another two rounds
of MDA were conducted in these districts in March 2005
and December 2008 and a further round was conducted in
December 2011, when MDA was extended to Tana River
and Lamu counties. Such intermittent MDA is not consist-
ent with GPELF recommendations to provide annual MDA
for 4–6 years and its impact on transmission is unclear.
Monitoring and evaluation is recognized as an es-
sential activity during implementation of any disease
control programme. The current WHO guidelines for
epidemiological monitoring of LF recommend selec-
tion of at least one sentinel site per 1 million people in
the implementation unit (IU) [1]. The selected villages
should have at least 500 persons so as to enable sample
collection of at least 300 specimens. Testing for circulat-
ing filarial antigen (CFA) using immunochromatographic
test (ICT) and parasitological detection of microfilariae
(MF) in blood have been the gold standard tests for moni-
toring the impact of LF elimination programmes [1].
Kenya’s Ministry of Health NTD Unit successfully
appealed to the World Health Organization Regional
Office for Africa (WHO-AFRO) and other partners for
support to re-establish the MDA programme starting in
2015. Subsequently, the WHO Country Office selected
the Eastern and Southern Africa Centre of International
Parasite Control (ESACIPAC), which is part of the
Kenya Medical Research Institute (KEMRI), to conduct a
comprehensive epidemiological assessment of LF infection
before re-starting the MDA campaign in the coastal region
of Kenya. The present paper reports results from this
assessment and provides critical evidence that can be
used for making decisions on MDA in addition to provid-
ing a basis for future monitoring of the LF elimin-
ation programme in coastal Kenya.
Methods
Study design and survey sites
A cross-sectional survey was conducted in October 2015
in ten LF sentinel sites (villages) located across the coastal
region in Taita-Taveta, Kwale, Kilifi, Tana River and Lamu
counties. Five of the sites were those that were previously
selected by the LF elimination programme: Ndau Island
(Lamu), Kipini (Tana River), Masindeni and Jaribuni
(Kilifi), and Makwenyeni (Kwale). Five new sentinel sites
were selected in Tana-River (Mikinduni), Kilifi (Kinarani),
Kwale (Mirihini and Mwadimu), and Taita-Taveta (Kimor-
igo) to represent implementation units (sub-counties) that
were established after initial MDA implementation. The
five earlier sentinel sites were selected according to esti-
mated risk of LF as estimated from a previously pub-
lished report [5]. In the present study, health workers at
the county level assisted in the selection of the 5 new
sentinel sites. These new villages were purposively se-
lected to participate in the survey based on the pres-
ence of cases of the disease and/or environmental
factors indicating that LF transmission is likely to occur
as given in the WHO-AFRO guidelines for mapping of
lymphatic filariasis [6].
Study population and sample size
The target population consisted of residents of the ten
selected sentinel villages. The residents of villages in
Taita-Taveta, Kwale, Kilifi and Tana River live in dispersed
homesteads within their respective villages often located in
the countryside. However, the residents of Ndau Island live
in a relatively compact village with households being very
close together. Typically, villages in the Kenyan coastal
region have population of 600–900 persons [7]. Following
WHO guidelines that at least 300 persons be tested in
each sentinel site, the target sample population for the
survey was 3,000 study participants. The sampling
assumed that the average household size in coastal
Kenya consists of 5 members per family and 3 individuals
would agree to voluntarily participate in the survey. Thus,
an estimated 100 households were to be visited in each
village. Residents of the sentinel villages were recruited
into the study if aged 2 years or more and not severely ill.
Survey strategy
The LF survey was conducted using a house-to-house
approach by four teams. Each team consisted of two
laboratory technicians, two data collectors, a driver
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and a team leader. Additionally, the village chairman
and a local volunteer in each selected village joined
the survey team to assist with mobilization of community
members. Individuals in each sentinel village were sampled
through simple random house-to-house visits. Refusal to
participate in the survey was encountered but the target
sample was achieved in most sentinel sites.
A survey questionnaire was programmed onto mobile
smartphones (Samsung Galaxy Trend S7560) and used
to collect data from consenting participants (or parent/
guardian in case of children). The data collected using
the mobile smartphones included information on age,
history of previous residence, use of deworming tablets,
and long lasting insecticide-treated net (LLIN) ownership
and use. Data on blood collection and results of the ICT
test were also recorded onto the questionnaire. Addition-
ally, the smartphones were used to collect global position-
ing system (GPS) coordinates of each study household.
Laboratory procedures
Blood collection
The middle finger of consenting individuals was cleaned
using a cotton ball soaked in 70% isopropyl alcohol.
After drying, the tip of the finger was pricked using a
sterile lancet and blood immediately collected using
capillary tubes for ICT test (100 μl) and preparation of
dry blood spots (DBS) on TropBio filter paper (60 μl).
Serological tests will be performed later and described
elsewhere. Any individual who tested positive for filarial
antigens by ICT test, if consenting, was also tested for MF.
Details of each laboratory procedure are given below.
Immunochromatographic test (ICT)
Prior to survey initiation, quality control (QC) of the ICT
test kits (BinaxNow® Filariasis, Alere Inc., Orlando, USA)
received for the survey was performed in KEMRI-
ESACIPAC Regional NTD Reference Laboratory using
well characterized serum samples. All the test kits
assessed passed the QC analysis. In the field, 100 μl of
the blood was used for the ICT test. After application
of a whole blood sample to the ICT card, the results
were read exactly at 10 min as recommended by the
manufacturer. An additional 60 μl of finger prick blood
samples were collected from participants and applied
onto TropBio filter paper (TropBio Pty Ltd, Townsville,
Queensland, Australia) for future serological studies.
Microfilariae detection
Individuals who tested positive by ICT test were invited
for further testing for microfilariae in night time blood
samples collected between 20:00 h and 24:00 h. The
counting chamber method was used for examination
and enumeration of Wuchereria bancrofti MF in the
night blood specimens [8]. Briefly, 100 μl of blood was
mixed with 900 μl of 3% acetic acid and the samples
transported to KEMRI-ESACIPAC regional NTD reference
laboratory in Nairobi where MF were examined and
counted under a light microscope.
Data management and analysis
Participants’ responses were captured electronically into
Open Data Kit (www.opendatakit.org/), which included
in-built data quality checks to prevent data entry errors.
Filarial infection was defined as a positive ICT result.
Observed overall prevalence of filarial infection was
calculated at sentinel site and county levels. 95% confi-
dence intervals (CIs) were obtained by binomial logistic
regression, taking into account clustering by households.
Prevalence by sex and age group was calculated and 95%
CIs determined using a Generalized Least Squares (GLS)
random effects model that adjusts for household cluster-
ing. For purposes of this analysis, the following age groups
were used: < 10, 10–17 and ≥ 18 year olds. The overall and
village level proportion estimates of reported LLIN use
were estimated and 95% CIs were determined using
Generalized Linear Latent and Mixed Models (GLLAMM)
adjusted for clustering by households. Overall, cross-county
analysis of the impact of LLIN use on participant infection
status was analysed, first using univariable analysis allowing
for factors associated with filarial infection (i.e., age group
and gender) and described as odds ratios (OR), using mixed
effects logistic regression at both household and county
levels. For multivariable analysis, adjusted OR (aOR) were
obtained by mutually adjusting all minimum generated
variables using multivariable mixed effects logistic re-
gression at 95% CIs taking into account both household
and county levels.
The mean coordinates of all households sampled in
each village were used to obtain geographic locations of
the sentinel sites that were mapped using Arc GIS Desktop
version 10.2.2 software (Environmental Systems Research
Institute, Inc., Redlands, CA). All statistical analyses were
carried out using STATA version 14.0 (STATA Corporation,
College Station, TX, US).
Results
Sentinel site surveillance
Ten sentinel sites (villages) were surveyed between 8
and 18th October 2015 in Kwale, Kilifi, Tana River, Lamu
and Taita-Taveta counties in Coastal Kenya (Fig. 1). A
total of 2,996 participants agreed to be registered for the
survey, but 20 individuals (0.67%) either withdrew or did
not provide a blood sample, hence final analysis was
done for the remaining 2,976 participants. Samples for
CFA testing using ICT test and dry blood spots (DBS)
for serological assays were obtained and prepared for
2,976 participants and 2,972 participants, respectively.
The reported age of individuals ranged from 2 to 100 years,
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with a median of 18 years (IQR = 31 years). Of the
enrolled participants, 1,260 (42.3%) were male.
Table 1 provides the projected population of the five
counties [9], demographic characteristics of the study
participants, overall LF infection prevalence by ICT
test in each county, and the adjusted odds ratios for
the factors associated with the LF infection. Overall, 38
of 2,976 (1.3%; 95% CI: 0.9–1.8) individuals were found
to be CFA positive using the ICT test. There was no
significant difference in the prevalence of CFA positive
individuals by sex (P = 0.148). Age-group classification
was arbitrarily assigned for younger children (<10 year
olds), older children (10–17 year olds), and adults
(≥18 year olds). The odds of CFA among persons aged
18 years and above was significantly higher than those
among younger persons (OR = 3.12; 95% CI: 1.16–8.43;
P = 0.024). The overall prevalence of CFA positive per-
sons in Kilifi and Kwale counties was 0.9% (95% CI:
0.4–1.8) and 1.1% (95% CI: 0.6–2.1), respectively, but
there were villages where the prevalence was up to
1.7%. There was no evidence of LF infection in the
sentinel sites in Tana River and Taita-Taveta counties.
Table 2 and Fig. 1 present the prevalence of CFA positive
individuals by sentinel site. Ndau Island/village in Lamu
County had the highest percentage of CFA positive persons,
with 20 of 320 (6.3%; 95% CI: 4.1–9.7) individuals found to
be antigen positive. Infection in Ndau Island was also ob-
served in young children with 6 of the 20 (30%) CFA posi-
tive individuals being children aged 10 years and below.
Out of the 38 persons found to be positive for LF infec-
tion by ICT test, 33 (86.8%) provided a night-time blood
sample for examination of MF. Assuming that all the indi-
viduals that were CFA negative by the ICT test were also
negative for microfilaraemia, the prevalence of MF was
highest in Ndau Island in Lamu County (1.9%; 95% CI:
0.9–4.1), but below 1% in three sentinel sites found to
have CFA positive individuals in Kwale and Kilifi counties.
The mean intensity of microfilaremia among MF positive
persons in Ndau Island was also higher (234 MF/ml; 95%
CI: 62–880) than in the other sentinel sites (Table 3).
Bed nets and deworming
Table 4 summarizes bed net ownership and usage among
the 10 sentinel villages. Overall, 97.6% (95% CI: 96.6–
Fig. 1 A map of the coastal region showing the location of the ten sentinel sites and lymphatic filariasis prevalence (%) levels by immunochromatographic
test. The highest prevalence of lymphatic filariasis infection was detected in Ndau Island in Lamu County
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98.5%) of the respondents reported owning at least one
LLIN, with 88.8% (95% CI: 87.0–90.7%) reporting to
have slept under a bed net the previous night. However,
bed net usage was observed to be lower in Mwadimu
village 73.3% (95% CI: 63.8–82.7) in Kwale County and
Ndau Island 75.0% (95% CI, 67.9–82.1) in Lamu County.
There was a significantly lower risk of LF infection
among participants who reported bed net use compared
to those who didn’t use a bed net (Table 1, OR = 0.40;
95% CI: 0.19–0.86; P = 0.019).
Of 2,950 responses about deworming, 1,184 individuals
(40%) reported receiving deworming drugs during the last
six months prior to the study with 68.6 and 21.0% receiv-
ing the treatment at school and home, respectively.
Discussion
The results of the current survey suggest that transmission
of LF infection in Tana River and Taita-Taveta counties
may be absent and could be used to request WHO-AFRO
to support the Kenyan LF programme to conduct trans-
mission assessment surveys in these counties. Kenya’s
LF elimination programme was launched in 2002, but
has however, seen inconsistent treatment delivery coupled
with challenges that resulted in MDA campaigns not
being conducted every year as recommended by the
GPELF (Table 5). A renewed commitment to re-start
the LF elimination programme in Kenya attracted support
Table 1 Demographic characteristics and filarial prevalence (%) by ICT test in 10 sentinel sites, coastal Kenya, October 2015
Demographic 2015 Population
projections
Sentinel
sites
n (%) CFA prevalence
(%) (95% CI)
Multivariable logistic
aOR (95% CI)a P-value
County
Kwale 792,698 3 877 (29.5) 1.1 (0.6–2.1) – –
Kilifi 1,307,185 3 911 (30.6) 0.9 (0.4–1.8) – –
Tana River 292,885 2 593 (19.9) 0 – –
Lamu 123,842 1 320 (10.8) 6.3 (4.1–9.7) – –
Taita-Taveta 347,195 1 275 (9.2) 0 – –
All counties 2,863,805 10 2,976 1.3 (0.9–1.8) – –
Sex
Male – 10 1,260 (42.3) 1.5 (0.9–2.4) 1.58 (0.85–2.95) 0.148
Female – 10 1,716 (57.7) 1.1 (0.7–1.7) Reference
Age group
< 10 – 10 865 (29.1) 0.7 (0.3–1.7) Reference
10–17 – 10 609 (20.5) 0.2 (0–1.2) 0.23 (0.03–2.05) 0.188
≥ 18 – 10 1,502 (50.5) 2.1 (1.5–2.9) 3.12 (1.16–8.43) 0.024*
LLIN use
Yes – 10 2,647 (88.9) 1.1 (0.8–1.6) 0.40 (0.19–0.86) 0.019*
No – 10 329 (11.1) 2.7 (1.4–5.2) Reference
aAdjusted odds ratios (aOR) were obtained by mutually adjusting all minimum generated variables using multivariable mixed effects logistic regression at 95% CI
taking into account households and county levels
*P < 0.05
Table 2 Surveyed households and sentinel site level circulating
filarial antigen (CFA) prevalence (%), coastal Kenya, October 2015
County/Village Households No. CFA positive/
No. examined
Prevalence (%)
(95% CI)
Kwale County
Makwenyeni 69 5/297 1.7 (0.7–3.9)
Mwadimu 67 5/290 1.7 (0.7–4.0)
Mirihini 52 0/290 0
Kilifi County
Kinarani 94 1/307 0.3 (0–2.4)
Jaribuni 93 2/298 0.7 (0.2–2.6)
Masindeni 96 5/306 1.7 (0.7–3.9)
Tana River County
Mikinduni 75 0/294 0
Kipini 83 0/299 0
Lamu County
Ndau 105 20/320 6.3 (4.1–9.7)
Taita-Taveta County
Kimorigo 94 0/275 0
All villages 828 38/2,976 1.3 (0.9–1.9)
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from the WHO-AFRO Regional Office and other partners
and an MDA campaign was conducted in October 2015.
This study was undertaken to provide the status of LF in-
fection in the Kenyan coastal region, which is required in
order to inform decisions on MDA campaigns. Overall,
ICT positivity in most sentinel sites ranged between 0 and
1.7%. However, the LF infection data in sentinel sites in
Lamu, Kilifi and Kwale counties indicate that transmission
is still ongoing in these counties, thus justifying additional
rounds of MDA in the three counties. These data,
therefore, could allow the programme to focus the cur-
rently available resources in areas that have empirical evi-
dence of LF infection.
Ndau Island in Lamu County had a relatively higher
infection rate (6.3%) compared to the sentinel sites on
the mainland. The microfilarial density among MF positive
persons was also relatively higher in Ndau Island compared
to the other sentinel sites. Additionally, about 30% of LF
infections on this island was detected in children aged ten
years and below. Therefore, Ndau Island appears to be a
hotspot of LF transmission and could be an indication of a
similar situation in the other neighbouring islands. A previ-
ous study conducted in Ndau Island four years after a pilot
MDA campaign found MF prevalence to be 13.7% [10]. A
Table 3 Sentinel site microfilariae prevalence (%) and mean intensity (MF/ml), coastal Kenya, October 2015
Village No. CFA positive/No. examined No. examined for MFa No. MF positive Mean intensityb (MF/ml)
(95% CI)
MF prevalencec
(95% CI)
Kwale County
Makwenyeni 5/297 5 1 22 (3–156) 0.3 (0–2.4)
Mwadimu 5/290 4 1 10 (1–71) 0.3 (0–2.4)
Mirihini 0/290 0 0 0 0
Kilifi County
Kinarani 1/307 0 0 0 0
Jaribuni 2/298 1 0 0 0
Masindeni 5/306 4 1 5 (1–35) 0.3 (0–2.4)
Tana River County
Mikinduni 0/294 0 0 0 0
Kipini 0/299 0 0 0 0
Lamu County
Ndau 20/320 19 6 234 (62–880) 1.9 (0.9–4.1)
Taita Taveta County
Kimorigo 0/275 0 0 0 0
All villages 38/2,976 33 9 140 (39–502) 0.3 (0.2–0.6)
aOnly CFA positive individuals were examined for MF by microscopy
bThe mean intensity of MF was calculated among the CFA positive participants only
cAll CFA negative individuals were assumed to be negative for MF and thus included in the calculation of MF prevalence
Table 4 Bed net ownership and usage by sentinel village, coastal
Kenya, October 2015
Village Proportion possessing
at least one LLIN %
(95% CI)
LLIN usage,
previous night %
(95% CI)
Makwenyeni 99.7 (99.0–100) 89.2 (84.0–94.4)
Mwadimu 95.1 (90.8–99.3) 73.3 (63.8–82.7)
Mirihini 91.5 (84.2–98.7) 89.5 (82.0–96.9)
Kinarani 97.4 (91.2–99.6) 89.6 (83.9–95.4)
Jaribuni 99.5 (98.6–100) 92.7 (88.1–97.3)
Masindeni 98.4 (93.0–99.1) 88.1 (82.8–93.5)
Mikinduni 99.0 (95.8–100) 93.6 (89.5–97.7)
Kipini 100 (98.6–100) 99.5 (98.5–100)
Ndau 98.7 (96.7–100) 75.0 (67.9–82.1)
Kimorigo 96.7 (94.2–99.3) 96.7 (94.4–99.0)
All villages 97.6 (96.6–98.5) 88.8 (87.0–90.7)
Table 5 MDA implementation in Coastal Kenya showing overall
treatment coverage (%), 2002–2015
County 2002 2003 2005 2008 2011 2015
Kilifi MDA MDA MDA MDA MDA MDA
(Malindi) MDA MDA MDA MDA MDA
Kwale MDA MDA MDA MDA MDA
Tana River MDA MDA
Lamu MDA MDA
Taita-Taveta
Programme (drug) coverage 81.2 79.5 72.3 62.7 58.3 54.3
The original IUs have been revised due to several changes in administrative
structures. Malindi is currently a sub-county in Kilifi County. Source: WHO
preventive chemotherapy database (WHO/PCT databank) http://www.who.int/
neglected_diseases/preventive_chemotherapy/lf/en/ Accessed 06/11/2016
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survey conducted by our team in 2011, prior to the
first MDA in Lamu County under the LF elimination
programme, found an MF prevalence of 11.6% (MoH,
unpublished). The results of the current study, however,
demonstrate that the MDA campaign conducted in 2011
may be associated with a reduced prevalence of LF infec-
tion in the Island. Nonetheless, further epidemiological
studies in Ndau Island should be considered to identify fac-
tors responsible for continued transmission of LF infection.
A study in Leogane, Haiti examined factors that could con-
tribute to continued transmission of LF infection and found
that MDA non-compliance was significantly associated
with infection [11].
The current study found that most households possessed
at least one bed net and the majority of people interviewed
reported that they used the nets regularly. The high bed net
possession was corroborated by observation of many new
bed nets (some still unopened) during the current study
because the national malaria control programme had con-
ducted a mass LLIN distribution a few weeks prior to the
LF survey. Vector control is increasingly being recognized
as a possible complementary strategy for LF elimination
[12–14]. A previous study found that vector control in
Africa had increased significantly since 2005, with a three-
fold increase in LLIN ownership and IRS coverage [15]. A
few countries where there has been high LLIN coverage
have reported the possibility of LF elimination in the ab-
sence of a MDA programme. For example, the Gambia has
historical evidence of LF transmission [16–18], a long his-
tory of large scale bed net distribution [19, 20], and recent
reports suggest that LF is no longer a public health problem
in the country [21]. The current study observed signifi-
cantly lower LF prevalence and risk of infection among
individuals who reported bed net use thus suggesting that
LLINs may have played a complementary role in reducing
LF infection in the endemic Kenyan coastal region.
A study on the impact of permethrin-impregnated bed
nets on LF vector mosquitoes in villages in Kwale County
reported that LF is transmitted by both culicine and anoph-
eline mosquitoes. Of the LF vector species collected before
implementation of the intervention, 33.6% were members
of An. gambiae complex [with more than 98% being An.
gambiae (sensu stricto)], 30% were An. funestus, and 36.4%
were Culex quinquefasciatus [22]. A malaria entomologic
study reported that the primary vectors of malaria along
the coast of Kenya include An. funestus and An. gambiae
complex: An. gambiae (s.s.), An. arabiaensis, and An. merus
[23]. The WHO promotes integrated vector management
(IVM) to improve the cost effectiveness of vector-control
operations, and to strengthen the capacity of programmes,
partnerships and intersectoral collaboration in their efforts
to control, eliminate or eradicate vector-borne diseases
[24]. In areas with overlapping geographical distribution of
LF and malaria, particularly where both infections are
transmitted by the same species of mosquito vectors, the
IVM approach is recommended as useful and appropriate
for jointly managing control activities for the two diseases
[25]. Although pyrethroid resistance has become wide-
spread among anopheline and culicine mosquitoes [26–
28], the sustained use of insecticide-treated bed nets
has been associated with significant decrease in number
of culicine mosquitoes in houses [29], which should
therefore contribute to a reduction in LF transmission.
According to the 2010–2020 strategic plan of the GPELF,
the strategic aim is to provide access to MDA and other
measures to interrupt transmission in all endemic areas
[30]. The current study provided further evidence that
LLINs against malaria can indeed have complementary
impact against LF and thus significantly contribute towards
the goal to interrupt transmission of infection. This finding
could be used to strengthen the call to adopt IVM ap-
proach which requires coordinated control of both malaria
and lymphatic filariasis so that the two programmes could
benefit from each programme’s activities, thus enhancing
their overall impact on public health [24, 25]. Therefore,
the Kenyan LF and malaria programmes should consider
jointly undertaking mosquito vector control in the coastal
region so as to enhance their overall impact on public
health. This way, any residual LF transmission is likely to
be completely eliminated.
Albendazole is a broad spectrum anthelmintic and is
also used to treat LF infection, although the evidence on
its efficacy when used alone is conflicting; studies in
India demonstrated significant effects on both microfilariae
and antigenaemia [31], but a study in Ghana reported min-
imal efficacy [32]. The current study found substantial use
of deworming drugs, which could be due to the ongoing
national school-based deworming programme that provides
annual albendazole for the treatment of soil-transmitted
helminths [33]. A recent study conducted in an informal
settlement area in Nairobi revealed that there are many
NGOs and religious organizations that also provide alben-
dazole to school-age children in Kenya [34]. Nonetheless,
the results of the current study are similar to those from
previous work in a historically high LF endemic area in
Malindi sub-County in Kilifi County, which reported sus-
tained reduction in LF infection despite missing MDA
rounds [7]. Taken together, the data suggest that LLIN use
and deworming may have contributed to reduce LF infec-
tion despite the irregular implementation of MDA.
A number of tests are currently available for diagnosis
of W. bancrofti infection but thick blood smear microscopy
for detection of MF and ICT for testing for CFA were
chosen for monitoring and evaluation of LF elimination
programmes [1]. Previous evaluation of the ICT test in the
coastal Kenya setting, before start of MDA campaigns,
found the diagnostic tool to be 100% sensitive and specific
for LF [35]. However, a study in Cameroon has reported
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loss of sensitivity of ICT test in low prevalence settings and
raised concern regarding the use of this tool for monitoring
and evaluation of LF elimination programmes [36].
Additionally, results of studies carried out in Central
Africa have shown cross-reactivity of ICT test with Loa
loa and Onchocerca ochengi infections and raised some
doubts to the reliability of LF mapping data particularly
in areas of L. loa co-endemicity [37, 38]. Therefore, the
use of ICT test as the gold standard diagnostic tool in
this study may be considered as a limitation that may
significantly impact on the conclusions. Nonetheless,
there are studies suggesting that antifilarial antibody
testing could provide a more sensitive and specific meas-
ure of exposure to W. bancrofti in carefully selected popu-
lations in endemic areas and thus, may also be valuable as
a tool for monitoring and evaluation of LF elimination
programmes [39, 40]. Therefore, it might be useful to
conduct operational research using strategies that comple-
ment CFA testing with the sensitive and specific antibody
detection diagnostic assays to provide further information
on current LF transmission in these counties.
Conclusion
The current study suggests that LF transmission may be
absent in Taita-Taveta and Tana River counties in coastal
Kenya and therefore transmission assessment surveys
(TAS) should be considered with a view to stopping
MDA. By contrast, evidence for ongoing transmission in
Kwale, Kilifi and Lamu counties indicates the need for
further MDA rounds in these counties.
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